Revenue Growth

Performance

Commentary

Dechra’s existing business grew by 6.4% in EU Pharmaceuticals (excluding third party contract manufacturing which declined), and by 3.0% in NA Pharmaceuticals.

Relevance to Strategy

A key driver of our strategy is to deliver sustainable sales growth through delivering our pipeline, maximising our existing portfolio and expanding geographically.

Underlying Diluted EPS Growth

Performance

Commentary

This includes a 0.4% increase in underlying operating profit, further improved by lower net finance costs attributable to foreign exchange gains and a lower tax charge driven by tax rate impact of a change in geographical mix of profit.

Relevance to Strategy

Underlying diluted EPS is a key indicator of our performance and the return we generate for our stakeholders. It is one of the performance conditions of the LTIP.

Return on Capital Employed

Performance

Commentary

There was a small decline in ROCE during the year. The reduction is due to the increased investments in acquisitions during the year without the corresponding increase in underlying operating profit in the period. This still exceeds our target of 15%.

Relevance to Strategy

As we look to grow the business, it is important that we use our capital efficiently to generate returns superior to our cost of capital in the medium to long term. It underpins the performance conditions of the LTIP.

Cash Conversion

Performance

Commentary

Cash conversion increased sharply during the year as a result of strong cash collection in quarter four following the sales spike in quarter three.

Relevance to Strategy

Our stated aim is to be a cash generative business. Cash generation supports investment in the pipeline, acquisition and people.

New Product Revenue

Performance

Commentary

New product revenues reflect the strong market penetration of products launched in the year to 30 June 2020 and the previous four years.

Relevance to Strategy

This measure shows the delivery of revenue in each year from new products launched in the prior five years, on a rolling basis. It shows the performance of our R&D and sales and marketing organisations when launching newly developed or in-licensed products.

Lost Time Accident Frequency Rate (LTAFR)

Performance

Commentary

The LTAFR decreased from 0.21 to 0.17. None of these incidents resulted in a work-related fatality or disability.

Relevance to Strategy

The safety of our employees is core to everything we do. We are committed to a strong culture of safety in all our workplaces.

Employee Turnover

Performance

Commentary

We saw a decrease in employee turnover in the period despite operating in competitive markets.

Relevance to Strategy

Attracting and retaining the best employees is critical to the successful execution of our strategy.

Key to Strategic Growth Drivers:

  • Pipeline Delivery
  • Portfolio Focus
  • Geographical Expansion
  • Acquisition

Key to Strategic Enablers

  • Technology
  • People
  • Manufacturing and Supply Chain

Key

  • Long Term Incentive Plan (LTIP) performance condition